In November 2017, ASCLD Representatives met with representatives from the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) to talk about resources related to the opioid crisis and other emerging drugs and new psychoactive substances (NPS).  As a result of these discussions, ASCLD is pleased to provide the following resource information here to help labs deal with this national emergency.

Opioid Resources for Forensic Laboratories

  • ASCLD Opioid Press Release:  LINK
  • ASCLD Position Statement to the President’s Commission on Combating Drug Addiction and the Opioid Crisis:  LINK
  • Drug analytical data monographs (SWGDRUG):  http://www.swgdrug.org/monographs.htm
  • Electronic Mass Spectral Library (SWGDRUG):  http://www.swgdrug.org/ms.htm
  • Opioid storage information (DEA):  https://www.deadiversion.usdoj.gov/21cfr/cfr/1301/1301_75.htm
  • DEA’s Real Time Communication Network – For access, provide the information below to Associate Laboratory Director Agnes Winokur at  agnes.d.winokur@usdoj.gov. Once the vetting process is complete, the individual will be added to the system and  begin receiving emails from synth-opioids@usdoj.gov.  Any emails sent to synth-opioids@usdoj.gov will be automatically shared with everyone in the group.  Please note that due to the large demand of requests to join the network, the vetting process is being modified by the DEA Chief Counsel. This may impact the timeliness of a response.
    • Name and Title
    • Name of Organization
    • Location of Organization
    • Contact Information
    • Curriculum Vitae
  • The DEA Laboratory system will assist in providing reference materials, which are not commercially available, to requesting forensic laboratories.  In the past they have provided some commercially available material due the exorbitant cost. However, they do not have the resources to be the nation’s drug reference material supplier. The procedure to obtain reference materials simply involves contacting the DEA regional laboratory in your area and requesting the material via a formal letter. If the local lab does not have the material, the DEA Special Testing and Research Laboratory may be able to synthesize material, if none is available.
  • New Jersey Fusion Center Drug Monitoring Initiative (DMI) Drug Identification Guide:  https://publicintelligence.net/njroic-drug-identification-guide/